» Articles » PMID: 34610172

Influence of COVID-19 Confinement on the Size of Malignant Skin Tumours Surgically Removed at a Spanish Hospital

Overview
Specialty Dermatology
Date 2021 Oct 5
PMID 34610172
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The COVID-19 pandemic required people to confine themselves to their homes where possible, and disrupted normal hospital activities. We examine whether this lockdown generated changes in the size of the tumours. We compared the dimensions of the surgically removed malignant skin tumours from the first 150 patients treated after the confinement ended in Spain (22 May 2020) with those of the last 150 patients to receive such treatment before the confinement began (13 March 2020). Data on tumour surface area were collected from pathology reports. Overall, no significant difference was seen in the tumour sizes. However, among men, the tumours removed after confinement were significantly larger (P < 0.05). Controversy exists over how the reduction in the number of tumours diagnosed during lockdowns might have influenced the characteristics of tumours. In this study, no overall difference was seen in the size of the tumours removed, although those removed from men after confinement were larger.

Citing Articles

Impact of COVID-19 pandemic on the diagnosis of patients with skin cancer: a systematic review protocol.

Zadeh S, Rezaei Y, Barahimi A, Abbasi E, Malekzadeh R BMJ Open. 2023; 13(3):e069720.

PMID: 36898745 PMC: 10008412. DOI: 10.1136/bmjopen-2022-069720.


The impact of COVID-19 on nonmelanoma skin cancer: the experience of an Irish dermatology department. Comment on: 'Influence of Covid-19 confinement on the size of malignant skin tumours surgically removed at a Spanish hospital'.

Wolinska A, Murray G, Bowe S, Collins S, Feighery C, Murad A Clin Exp Dermatol. 2022; 47(8):1582-1583.

PMID: 35426963 PMC: 9111601. DOI: 10.1111/ced.15225.

References
1.
Andrew T, Alrawi M, Lovat P . Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic. Clin Exp Dermatol. 2020; 46(1):145-146. PMC: 7436874. DOI: 10.1111/ced.14411. View

2.
Danesh M, Porter M, Brag K, Salian P, Olbricht S . COVID-19 impacts on dermatologic surgery patients: A single institution experience. J Am Acad Dermatol. 2021; 84(6):1698-1699. PMC: 7906857. DOI: 10.1016/j.jaad.2021.02.060. View

3.
Capitelli-McMahon H, Hurley A, Pinder R, Matteucci P, Totty J . Characterising non-melanoma skin cancer undergoing surgical management during the COVID-19 pandemic. J Plast Reconstr Aesthet Surg. 2020; 74(3):644-710. PMC: 7605727. DOI: 10.1016/j.bjps.2020.10.042. View

4.
Gaunt N, Green R, Motta L, Jamieson L . Skin cancers in lockdown: no impact on pathological tumour staging. Br J Dermatol. 2021; 185(4):844-846. PMC: 8239654. DOI: 10.1111/bjd.20438. View

5.
Valenti M, Pavia G, Gargiulo L, Facheris P, Nucca O, Mancini L . Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospital. Int J Dermatol. 2021; 60(7):860-863. PMC: 8014866. DOI: 10.1111/ijd.15501. View